Gene-Edited Seeds Market (2026-2036)

Row crop applications in corn, soybean and wheat account for the largest share of market value through most of the forecast period, reflecting the scale of acreage already served by Corteva, Bayer, BASF and Syngenta's gene editing pipelines, while specialty and horticultural crops developed through licensed trait platforms represent the fastest growing category as companies such as Pairwise, Tropic Biosciences and Cibus extend gene editing beyond staple row crops.

A gene-edited seed is a seed developed using precision genome-editing technologies, such as CRISPR-Cas9, CRISPR-Cas12a, base editing, prime editing, TALENs, or oligonucleotide-directed mutagenesis, to make targeted changes to a plant's genome. Unlike conventional transgenic approaches, many gene-editing applications modify the plant's existing DNA without introducing foreign genetic material, although certain editing approaches can involve targeted DNA insertion or replacement. This distinction has contributed to differentiated regulatory treatment for certain gene-edited crops in a growing number of jurisdictions, although the specific requirements vary by country. The category spans staple row crops such as corn, soybean, wheat, rice, and canola, where large diversified seed companies play a major role in commercialization, as well as specialty and horticultural crops such as bananas, tomatoes, berries, and mushrooms, where technology-focused developers increasingly work with established seed, agricultural, and food-industry partners.

The competitive landscape reflects two broad business models. Diversified agricultural companies, including Corteva, Bayer, BASF, Syngenta, KWS SAAT, and Groupe Limagrain, integrate gene editing into their existing germplasm, breeding, and trait-development pipelines, alongside conventional breeding and, in some markets, transgenic products. A second group comprises specialized gene-editing and plant-biotechnology companies, including Cibus, Pairwise, Inari Agriculture, Tropic Biosciences, KeyGene, and Qi Biodesign. These companies use different commercial models, ranging from developing and commercializing their own edited seed products to licensing gene-editing technologies and traits or collaborating with established seed companies. Inari, for example, combines AI-powered predictive design with multiplex gene editing to develop commercial seed solutions, while KeyGene provides gene-editing and other plant-breeding technologies through licensing arrangements. Corteva's September 2024 $25 million investment in Pairwise and the formation of a joint venture illustrate the increasing collaboration between diversified seed companies and specialized gene-editing technology developers.

Regulatory treatment continues to diverge by geography, although several jurisdictions have established pathways that distinguish certain gene-edited plants from conventional transgenic GMOs. In the United States, USDA APHIS's 2020 SECURE rule was vacated by a federal court in December 2024, returning APHIS to its pre-2020 biotechnology regulatory framework while the agency works through the resulting regulatory transition. The European Union adopted a new regulatory framework for plants obtained through certain new genomic techniques in 2026, establishing NGT-1 and NGT-2 categories. NGT-1 covers plants with a limited number and type of genetic changes that could have been achieved through conventional breeding, while NGT-2 covers other NGT plants and retains more extensive regulatory requirements. The United Kingdom has established a separate precision-breeding framework for England, while India provides a regulatory pathway for certain SDN-1 and SDN-2 genome-edited plants that do not contain exogenous DNA. China has also established dedicated safety-evaluation guidelines for gene-edited plants. Consequently, gene-edited seeds do not receive uniform regulatory treatment globally; rather, the regulatory landscape is evolving toward differentiated pathways based on the nature and characteristics of the genetic modification.